TSH normal range by age: how to interpret thyroid results without panic

Your TSH came back at 5.2 mIU/L. The lab flagged it red. Your doctor mentioned “subclinical hypothyroidism.” Maybe medication. Maybe more tests.

If your TSH is in range but symptoms persist, use the follow-up guide on normal TSH with ongoing symptoms to discuss free T4, antibodies, iron, B12, and metabolic labs with a clinician.

But you’re 68. And here’s what the lab report probably didn’t say: a TSH of 5.2 at your age may sit comfortably inside the age-adjusted normal range. The same number that triggers a prescription at 35 may signal nothing — or even something protective — at 70.

The problem is that most labs in 2026 still use a single “adult” reference range (roughly 0.4–4.0 mIU/L) regardless of whether you’re 25 or 85. Research over the last decade has made it overwhelmingly clear that this is wrong. TSH naturally climbs with age, and what looks abnormal on a young scale is often physiology, not disease.

What you’ll learn:

• The 2026 age-specific TSH reference ranges by decade, with exact numbers
• Why TSH between 4 and 7 mIU/L after 65 is usually not hypothyroidism
• The “age divided by 10” rule and how to use it on your own labs
• How TSH connects to biological age, longevity, and cardiovascular risk
• When subclinical hypothyroidism actually needs treatment — and when it doesn’t

---

What is TSH?

Quick definition: TSH (thyroid-stimulating hormone) is a pituitary hormone that tells your thyroid gland how much T4 and T3 to produce. Higher TSH means your pituitary is asking the thyroid to work harder; lower TSH means it’s asking it to slow down.

TSH operates on a negative feedback loop. When circulating thyroid hormones (mostly T4) drop, the pituitary releases more TSH to push production back up. When thyroid hormones rise, TSH falls. This is why TSH is the most sensitive early marker of thyroid dysfunction — it moves before T4 and T3 do.

A high TSH almost always means the body is trying to make more thyroid hormone than it currently is (hypothyroidism, or an early version of it). A low TSH usually means the opposite: too much thyroid hormone is circulating, so the pituitary brakes (hyperthyroidism).

Why TSH matters more than T4 alone

Free T4 can sit inside the “normal” range while TSH is already elevated. That’s exactly what subclinical hypothyroidism is: TSH is climbing because the pituitary senses a developing problem, but T4 hasn’t fallen yet. By the time T4 drops out of range, the dysfunction is no longer subclinical — it’s overt.

This is also why testing T4 without TSH is a poor screening strategy. TSH is the early warning. T4 is the confirmation.

---

The standard TSH reference range: where the numbers come from

Most labs report TSH normal as approximately 0.4–4.0 mIU/L (some go up to 4.5). This range comes from population studies of healthy adults across all ages, with reference limits set at the 2.5th and 97.5th percentiles.

The problem: that “all ages” sample is dominated by younger adults. When you split the data by decade, the upper limit drifts higher with every decade past 50.

The age-stratified picture

Large epidemiological studies — most notably the U.S. NHANES dataset and several European population surveys — show a consistent pattern:

Age band	TSH 2.5th–97.5th percentile (mIU/L)
20–39 years	~0.45–4.12
40–49 years	~0.50–4.20
50–59 years	~0.55–4.50
60–69 years	~0.65–5.51
70–79 years	~0.85–5.89
80+ years	~0.78–6.70

The lower limit barely moves. The upper limit climbs roughly 0.3–0.5 mIU/L per decade after 50. By the 80s, the legitimate upper bound is around 6.7 mIU/L — nearly 70% higher than the conventional 4.0 cutoff most labs print.

What this means in practice

Using the conventional 4.0 cutoff misclassifies a huge share of older adults as hypothyroid when they’re physiologically normal. One large French population study estimated that switching to age-appropriate reference values would reclassify 50–65% of women and 33–38% of men over 60 who currently sit just above 4.0 mIU/L. That’s a staggering rate of overdiagnosis.

---

The “age divided by 10” rule

A simple bedside heuristic some endocrinologists use:

Upper TSH limit (mIU/L) ≈ age ÷ 10

So a 70-year-old has an effective upper limit of ~7.0 mIU/L. An 80-year-old, around 8.0. A 50-year-old stays at ~5.0.

It’s an approximation, not a clinical guideline you should use to override your doctor. But it captures the underlying biology well: the upper end of “normal” rises with age, and the rate is roughly linear past midlife. If your TSH is 5.5 at 65, the age÷10 rule says you’re inside normal (6.5). The standard lab cutoff says you’re abnormal. The age-adjusted research backs the rule.

When the rule breaks

This shortcut applies only to the upper limit. The lower limit doesn’t follow the same pattern — a TSH of 0.2 is suspicious at any age and may signal hyperthyroidism, atrial fibrillation risk, or excess thyroid hormone replacement. The age÷10 trick is one-directional.

It also doesn’t apply during pregnancy, on thyroid medication, or in the presence of pituitary disease.

---

Why does TSH rise with age?

This is the question that flips the whole interpretation. If higher TSH in older adults were simply “early hypothyroidism waiting to declare itself,” it would be a problem to fix. But the data points elsewhere.

Theory 1: Pituitary set-point shifts

The hypothalamic-pituitary-thyroid axis recalibrates with age. The set-point — the TSH value at which the pituitary stops pushing — drifts higher. This isn’t disease; it’s the same kind of slow physiological remodeling that happens to many endocrine axes (cortisol, growth hormone, sex hormones).

Theory 2: Reduced peripheral T3 conversion

With aging, the conversion of T4 to the more active T3 slows down. Slightly higher TSH compensates by stimulating more T4 output, keeping T3 adequate. The system is doing extra work to maintain the same end result.

Theory 3: Slight TSH elevation may be protective

This is the surprising one. Multiple cohort studies, including data from the Leiden 85-Plus Study, found that adults over 85 with TSH levels in the 4–7 mIU/L range had lower all-cause mortality than those with TSH at the conventional “ideal” range of 1.0–2.5. The same pattern shows up in centenarians, who tend to have higher-than-average TSH.

The mechanism may involve a slower basal metabolic rate, less oxidative stress, and reduced cellular wear. A thyroid that’s slightly less aggressive may be a thyroid that ages better. This connects to the broader biology of aging — see our deep dive on thyroid function and metabolic aging for the longevity context.

Want the bigger picture? Read our overview of how biological age is calculated to see where thyroid signals fit into the larger aging score.

---

Subclinical hypothyroidism: what it actually means

This is the diagnosis you’ll see most often in age-related TSH confusion.

Subclinical hypothyroidism: TSH is above the reference upper limit, but free T4 is still normal. The patient usually has no symptoms or only vague ones (fatigue, mild weight gain, cold intolerance).

It’s split into two grades:

• Mild (grade 1): TSH 4.0–10.0 mIU/L
• Severe (grade 2): TSH > 10.0 mIU/L

Prevalence climbs sharply with age: 10–15% of adults over 65 meet the criteria using the conventional cutoff, and up to 20% over 85. Most of those cases — especially in the mild grade — are now considered overdiagnosis when measured against age-specific ranges.

What major 2026 guidelines actually recommend

The current consensus across the American Thyroid Association, European Thyroid Association, and most internal medicine guidelines:

• TSH < 7 mIU/L in adults over 65, asymptomatic: observe, do not treat
• TSH 7–10 mIU/L, asymptomatic: consider treatment only if cardiovascular risk factors, positive thyroid antibodies, or rising trend
• TSH > 10 mIU/L: treatment usually recommended regardless of age
• Symptomatic patients: lower threshold for treatment

The shift from automatic-treat to age-aware monitoring is one of the cleanest examples of evidence reshaping practice in the last decade. For a full breakdown of the 5-question framework that should precede any levothyroxine prescription, see our deep dive on when subclinical hypothyroidism actually needs treatment.

---

How to read your own TSH result

A practical framework:

Step 1: Check the lab’s reference range and your age band

If your lab still uses a single 0.4–4.0 (or 0.4–4.5) cutoff and you’re over 50, mentally apply the age-stratified ranges from the table above. Don’t redefine the result yourself — just understand whether the “abnormal” flag is age-appropriate.

Step 2: Look at the magnitude, not just the flag

A TSH of 4.5 in a 30-year-old is genuinely above range. A TSH of 4.5 in a 70-year-old sits comfortably inside the age-adjusted range. Same number, different interpretation.

Step 3: Check free T4

If your panel includes both free T4 and free T3, the focused free T3 vs free T4 guide explains which result usually changes the interpretation.

If TSH is mildly elevated but free T4 is solidly in range, you have subclinical status. That’s a watch-and-track situation, not a treat-immediately situation (unless you’re symptomatic or TSH > 10).

Step 4: Check thyroid antibodies if not done

Positive anti-TPO (thyroid peroxidase) antibodies indicate Hashimoto’s autoimmune thyroiditis. With high antibodies, subclinical hypothyroidism is more likely to progress to overt disease, and treatment thresholds are typically lower.

Step 5: Look at the trend, not the single reading

A single TSH measurement is noisy. Day-to-day variation can reach 0.5–1.0 mIU/L without any pathology. Diurnal variation matters too — TSH peaks at night and drops by mid-morning. A single value is a snapshot; two or three values over 6–12 months show the actual trajectory.

This is exactly the kind of pattern continuous tracking is built for. Single labs are interpretation traps. Trends are signal.

---

TSH and longevity: what the research says

Several long-running cohort studies have looked at TSH as a longevity biomarker, and the findings cluster around a J-shaped or U-shaped relationship.

Cardiovascular events

A large analysis from the Rotterdam Study found that adults with TSH in roughly the 60th–80th percentile (about 1.5–2.8 mIU/L for the general adult population) had the lowest risk of cardiovascular events and all-cause death. Both very low TSH (<0.4, suggesting hyperthyroidism or overtreatment) and severely high TSH (>10, overt hypothyroidism) increased risk.

Why overtreatment matters

This is the underrecognized cost of treating “subclinical hypothyroidism” too aggressively. Levothyroxine that pushes TSH below 0.4 increases the risk of atrial fibrillation, osteoporosis, and bone fractures — especially in postmenopausal women and adults over 65. The treatment harm can exceed the disease.

The centenarian pattern

Studies of healthy centenarians and their offspring consistently find slightly higher TSH and slightly lower free T3 than younger controls. This “slow thyroid” pattern correlates with exceptional longevity. It’s not the only factor, but it’s a recurring signal.

---

Subclinical hyperthyroidism: the other side

Low TSH gets less attention but matters more for short-term risk.

Subclinical hyperthyroidism: TSH below the lower reference limit (typically <0.4 mIU/L) with normal free T4 and T3.

Causes include early Graves’ disease, autonomously functioning thyroid nodules, multinodular goiter, and — most commonly in older adults — overtreatment with levothyroxine.

Risks of untreated subclinical hyperthyroidism in older adults:

• 2-3x increased risk of atrial fibrillation
• Accelerated bone loss and fracture risk
• Cardiovascular mortality bump in TSH <0.1

This is one of the reasons the “more aggressive treatment” approach to mildly elevated TSH backfires: a percentage of those patients end up with iatrogenically suppressed TSH and elevated atrial fibrillation risk.

---

Special populations: when standard rules don’t apply

Pregnancy

TSH should be lower during pregnancy. First trimester reference range is approximately 0.1–2.5 mIU/L; second and third trimester, 0.2–3.0 mIU/L. Even subclinical hypothyroidism in pregnancy is treated more aggressively because adequate maternal thyroid hormone is essential for fetal neurodevelopment.

On thyroid hormone replacement

If you’re already on levothyroxine, the target TSH is typically 0.5–3.0 mIU/L. Below 0.4 means over-replacement (atrial fibrillation and bone loss risk). Above 3.0 may mean under-replacement, especially with persistent symptoms.

Acute illness

TSH can swing wildly during serious illness, surgery, or recovery. This is non-thyroidal illness syndrome (sometimes called “sick euthyroid”). Don’t trust a TSH measurement taken during or immediately after an acute hospitalization — repeat it 6–8 weeks later when you’re back to baseline.

Pituitary disease

In rare cases, the pituitary itself fails or produces an inappropriate TSH (TSH-secreting tumors are uncommon but exist). If TSH and free T4 move in the same direction (both high or both low), the issue may be central rather than thyroidal — that needs endocrinology referral.

---

How SuperAge helps you track TSH alongside aging

A single TSH value, interpreted against a one-size-fits-all reference range, is the single biggest reason for thyroid overdiagnosis and overtreatment after 60. The fix is two changes: age-aware ranges and trend tracking instead of point-in-time judgment.

Lab biomarker tracking with biological-age context

SuperAge lets you log TSH, free T4, thyroid antibodies, and adjacent biomarkers (lipids, fasting glucose, hs-CRP, ferritin) into a single longitudinal record. Each reading gets timestamped alongside your wearable signals — HRV, resting heart rate, VO2 max, sleep, recovery — so you can see whether a slightly elevated TSH coincides with declining recovery, rising resting heart rate, or other early warning patterns. A truly isolated mild TSH bump usually isn’t worth panicking over. A TSH that’s rising while other aging signals worsen tells a different story.

Age-adjusted interpretation context

Instead of showing labs flagged red against a young-adult reference range, SuperAge applies age-stratified context so you see whether your value sits inside the normal distribution for your decade. That alone resolves a large share of the unnecessary worry around mildly elevated TSH after 50.

Trend over snapshot

Single labs are noisy. SuperAge plots your TSH trajectory across years so you can distinguish day-to-day variability (~±0.5 mIU/L) from a real upward drift that may warrant follow-up. The same trend logic applies to all your biomarkers — see how this works across the broader PhenoAge calculator framework.

---

Frequently asked questions

Is a TSH of 5 dangerous?

A TSH of 5.0 mIU/L is mildly above the conventional adult cutoff but inside the normal age-adjusted range for anyone over about 60. In a younger person, it suggests subclinical hypothyroidism and deserves follow-up (repeat in 2–3 months, check anti-TPO antibodies and free T4). In an older adult without symptoms, it’s usually monitored, not treated.

Why does TSH increase with age?

Three reasons combine: the pituitary-thyroid set-point drifts higher, T4-to-T3 conversion slows so the system needs more TSH to maintain T3 levels, and the body may adapt to a slightly lower metabolic rate that correlates with better longevity. The rise is physiologic, not pathologic, in most older adults.

What is the optimal TSH for longevity?

Research suggests the lowest cardiovascular and all-cause mortality risk in the general adult population sits between roughly 1.5 and 2.8 mIU/L. In adults over 80, slightly higher TSH (4–7 mIU/L) has been associated with better outcomes in some studies. Avoid both extremes: TSH below 0.4 (hyperthyroidism or overtreatment) and TSH above 10 (overt hypothyroidism).

Should subclinical hypothyroidism be treated after 65?

Current 2026 guidelines say no for asymptomatic adults over 65 with TSH below 7 mIU/L. Between 7 and 10 mIU/L, treatment is considered if there are cardiovascular risk factors, positive antibodies, or a clear upward trend. Above 10 mIU/L, treatment is generally recommended at any age. Symptoms also lower the threshold for treatment.

Can stress raise TSH?

Acute physical stress (serious illness, surgery, severe sleep deprivation) can transiently suppress TSH via non-thyroidal illness syndrome. Chronic psychological stress has a weaker and less consistent effect on TSH directly, but it strongly affects related hormones (cortisol, sex hormones) that influence overall thyroid axis function. For more on chronic stress and aging, see our guide on chronic cortisol and biological age.

How often should I retest TSH?

For a normal TSH with no symptoms: every 2–3 years for adults under 60, annually for adults over 60. For a borderline or mildly elevated TSH being monitored: every 6–12 months. For TSH on treatment after a dose change: 6–8 weeks later, then every 6–12 months once stable. Never base a treatment decision on a single TSH reading — repeat at least once before acting.

---

Key takeaways

• The single adult TSH cutoff of 4.0 mIU/L is outdated — labs increasingly recognize age-specific reference ranges with upper limits of 5.5 (60s), 5.9 (70s), and 6.7 (80+) mIU/L.
• Mildly elevated TSH after 65 is rarely disease — it’s usually physiological pituitary-thyroid set-point drift and may even associate with better longevity.
• The “age divided by 10” rule gives a quick estimate of the upper normal limit (70-year-old → 7.0 mIU/L) but doesn’t replace clinical judgment.
• TSH between 1.5 and 2.8 mIU/L is associated with the lowest cardiovascular and all-cause mortality in general adult populations.
• Subclinical hypothyroidism under 10 mIU/L in asymptomatic older adults is increasingly monitored, not treated — overtreatment causes atrial fibrillation and bone loss.
• Trend matters more than a single reading — one TSH value is noisy; track at least two or three over 6–12 months before making treatment decisions.

---

Start tracking your thyroid trajectory the right way

A single TSH on a single lab report is one data point against a population average that may not match your age, your physiology, or your aging trajectory. The same number that triggers an overdiagnosis at 70 may be a meaningful warning at 35. Context is everything.

Ready to interpret your labs with age-aware context? Download SuperAge and start tracking TSH alongside your full biological age picture — so a single flagged result becomes a real signal, not a panic trigger.

---

References

1. Bremner AP et al. — Age-related changes in thyroid function: longitudinal study of TSH in adults. Journal of Clinical Endocrinology & Metabolism.
2. Surks MI, Hollowell JG — Age-specific distribution of serum TSH and antithyroid antibodies in the U.S. population: implications for the diagnosis of subclinical hypothyroidism. JCEM, NHANES III analysis.
3. Vadiveloo T et al. — The Thyroid Epidemiology, Audit and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. JCEM.
4. Gussekloo J et al. — Thyroid status, disability and cognitive function, and survival in old age (Leiden 85-Plus Study). JAMA.
5. Atzmon G et al. — Extreme longevity is associated with increased serum thyrotropin. JCEM, centenarian cohort.
6. Calsolaro V et al. — Reference intervals for thyroid hormones for the elderly population and their influence on the diagnosis of subclinical hypothyroidism. PMC10040197.
7. Pearce SHS et al. — 2013 ETA Guideline: Management of Subclinical Hypothyroidism (with 2026 update commentary).
8. Razvi S et al. — Thyroid hormones and cardiovascular function and disease. JACC review.

---

Last updated: 2026-05-25. The information provided does not replace professional medical advice. Always consult your healthcare provider for personalized interpretation of thyroid function tests, especially before starting, adjusting, or stopping medication.